Eli Lilly Executive Who Oversaw Development of Blockbuster Diabetes Drug Is Set to Retire

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The Eli Lilly & Co. executive who oversaw development of Mounjaro, its blockbuster diabetes medicine that’s also used for weight loss, will retire at the end of the year.

Germany Brings Back Mothballed Coal Plants to Help Keep Lights OnSaudis to Stick With 1 Million-Barrel Oil Supply Cut For NowEmerging Market Bond Yields Are Sending a Worrying SignalECB Interest Rate Hikes May Be Over, Centeno SaysEx-McKinsey Partner Set For EU Climate Commissioner Role After Surviving GrillingOcado CEO Still Believes Robots Can Make It the Tesla of GroceryOne Reason Buying a House Can Be So Hard: Big Take Podcast‘Soft Landing’ Prospects Improve With Better Central-Bank...

5% for First Time Since 2000Ocado CEO Still Believes Robots Can Make It the Tesla of GroceryGermany Brings Back Mothballed Coal Plants to Help Keep Lights OnSaudis to Stick With 1 Million-Barrel Oil Supply Cut For NowOne Investor’s Uphill Battle to Turn Rewilding Into a Multi-Billion Dollar IndustryOil falls in global market rout as OPEC+ leaders extend cutsInvestors Eye Profit Rebound After Yearlong Earnings RecessionFlaring Ticks Up in Texas Oil Patch, Showing Limits of ESG PressureClimate...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA declines to approve Eli Lilly's skin disease drug(Reuters) - The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings ...
Source: SaltWire Network - 🏆 45. / 63 Read more »

U.S. FDA declines to approve Eli Lilly's skin disease drug(Reuters) - The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings ...
Source: SaltWire Network - 🏆 45. / 63 Read more »